Point-of-Care Diagnostics-EMEA Market Status and Trend Report 2013-2023
Report Summary
Point-of-Care Diagnostics-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Point-of-Care Diagnostics industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Point-of-Care Diagnostics 2013-2017, and development forecast 2018-2023
Main market players of Point-of-Care Diagnostics in EMEA, with company and product introduction, position in the Point-of-Care Diagnostics market
Market status and development trend of Point-of-Care Diagnostics by types and applications
Cost and profit status of Point-of-Care Diagnostics, and marketing status
Market growth drivers and challenges
The report segments the EMEA Point-of-Care Diagnostics market as:
EMEA Point-of-Care Diagnostics Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Point-of-Care Diagnostics Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Glucose Monitoring Kits
Infectious Diseases Testing Kits
Cardiometabolic Monitoring Kits
Coagulation Monitoring Kits
Hematology Testing Kits
Urinalysis Testing Kits
Cholesterol Test Strips
Drugs-Of-Abuse Testing Kits
Tumor/Cancer Markers
Other
EMEA Point-of-Care Diagnostics Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Home
Hospitals
Ambulatory Care
EMEA Point-of-Care Diagnostics Market: Players Segment Analysis (Company and Product introduction, Point-of-Care Diagnostics Sales Volume, Revenue, Price and Gross Margin):
Abbott Laboratories
Abaxis
Alere
Bayer
Danaher Corporation
Becton Dickinson
Johnson & Johnson
Nipro
Roche Diagnostics
Siemens Healthcare
Samsung Medison
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Point-of-Care Diagnostics-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Point-of-Care Diagnostics industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Point-of-Care Diagnostics 2013-2017, and development forecast 2018-2023
Main market players of Point-of-Care Diagnostics in EMEA, with company and product introduction, position in the Point-of-Care Diagnostics market
Market status and development trend of Point-of-Care Diagnostics by types and applications
Cost and profit status of Point-of-Care Diagnostics, and marketing status
Market growth drivers and challenges
The report segments the EMEA Point-of-Care Diagnostics market as:
EMEA Point-of-Care Diagnostics Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Point-of-Care Diagnostics Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Glucose Monitoring Kits
Infectious Diseases Testing Kits
Cardiometabolic Monitoring Kits
Coagulation Monitoring Kits
Hematology Testing Kits
Urinalysis Testing Kits
Cholesterol Test Strips
Drugs-Of-Abuse Testing Kits
Tumor/Cancer Markers
Other
EMEA Point-of-Care Diagnostics Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Home
Hospitals
Ambulatory Care
EMEA Point-of-Care Diagnostics Market: Players Segment Analysis (Company and Product introduction, Point-of-Care Diagnostics Sales Volume, Revenue, Price and Gross Margin):
Abbott Laboratories
Abaxis
Alere
Bayer
Danaher Corporation
Becton Dickinson
Johnson & Johnson
Nipro
Roche Diagnostics
Siemens Healthcare
Samsung Medison
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF POINT-OF-CARE DIAGNOSTICS
1.1 Definition of Point-of-Care Diagnostics in This Report
1.2 Commercial Types of Point-of-Care Diagnostics
1.2.1 Glucose Monitoring Kits
1.2.2 Infectious Diseases Testing Kits
1.2.3 Cardiometabolic Monitoring Kits
1.2.4 Coagulation Monitoring Kits
1.2.5 Hematology Testing Kits
1.2.6 Urinalysis Testing Kits
1.2.7 Cholesterol Test Strips
1.2.8 Drugs-Of-Abuse Testing Kits
1.2.9 Tumor/Cancer Markers
1.2.10 Other
1.3 Downstream Application of Point-of-Care Diagnostics
1.3.1 Home
1.3.2 Hospitals
1.3.3 Ambulatory Care
1.4 Development History of Point-of-Care Diagnostics
1.5 Market Status and Trend of Point-of-Care Diagnostics 2013-2023
1.5.1 EMEA Point-of-Care Diagnostics Market Status and Trend 2013-2023
1.5.2 Regional Point-of-Care Diagnostics Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Point-of-Care Diagnostics in EMEA 2013-2017
2.2 Consumption Market of Point-of-Care Diagnostics in EMEA by Regions
2.2.1 Consumption Volume of Point-of-Care Diagnostics in EMEA by Regions
2.2.2 Revenue of Point-of-Care Diagnostics in EMEA by Regions
2.3 Market Analysis of Point-of-Care Diagnostics in EMEA by Regions
2.3.1 Market Analysis of Point-of-Care Diagnostics in Europe 2013-2017
2.3.2 Market Analysis of Point-of-Care Diagnostics in Middle East 2013-2017
2.3.3 Market Analysis of Point-of-Care Diagnostics in Africa 2013-2017
2.4 Market Development Forecast of Point-of-Care Diagnostics in EMEA 2018-2023
2.4.1 Market Development Forecast of Point-of-Care Diagnostics in EMEA 2018-2023
2.4.2 Market Development Forecast of Point-of-Care Diagnostics by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Point-of-Care Diagnostics in EMEA by Types
3.1.2 Revenue of Point-of-Care Diagnostics in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Point-of-Care Diagnostics in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Point-of-Care Diagnostics in EMEA by Downstream Industry
4.2 Demand Volume of Point-of-Care Diagnostics by Downstream Industry in Major Countries
4.2.1 Demand Volume of Point-of-Care Diagnostics by Downstream Industry in Europe
4.2.2 Demand Volume of Point-of-Care Diagnostics by Downstream Industry in Middle East
4.2.3 Demand Volume of Point-of-Care Diagnostics by Downstream Industry in Africa
4.3 Market Forecast of Point-of-Care Diagnostics in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF POINT-OF-CARE DIAGNOSTICS
5.1 EMEA Economy Situation and Trend Overview
5.2 Point-of-Care Diagnostics Downstream Industry Situation and Trend Overview
CHAPTER 6 POINT-OF-CARE DIAGNOSTICS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Point-of-Care Diagnostics in EMEA by Major Players
6.2 Revenue of Point-of-Care Diagnostics in EMEA by Major Players
6.3 Basic Information of Point-of-Care Diagnostics by Major Players
6.3.1 Headquarters Location and Established Time of Point-of-Care Diagnostics Major Players
6.3.2 Employees and Revenue Level of Point-of-Care Diagnostics Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 POINT-OF-CARE DIAGNOSTICS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Abbott Laboratories
7.1.1 Company profile
7.1.2 Representative Point-of-Care Diagnostics Product
7.1.3 Point-of-Care Diagnostics Sales, Revenue, Price and Gross Margin of Abbott Laboratories
7.2 Abaxis
7.2.1 Company profile
7.2.2 Representative Point-of-Care Diagnostics Product
7.2.3 Point-of-Care Diagnostics Sales, Revenue, Price and Gross Margin of Abaxis
7.3 Alere
7.3.1 Company profile
7.3.2 Representative Point-of-Care Diagnostics Product
7.3.3 Point-of-Care Diagnostics Sales, Revenue, Price and Gross Margin of Alere
7.4 Bayer
7.4.1 Company profile
7.4.2 Representative Point-of-Care Diagnostics Product
7.4.3 Point-of-Care Diagnostics Sales, Revenue, Price and Gross Margin of Bayer
7.5 Danaher Corporation
7.5.1 Company profile
7.5.2 Representative Point-of-Care Diagnostics Product
7.5.3 Point-of-Care Diagnostics Sales, Revenue, Price and Gross Margin of Danaher Corporation
7.6 Becton Dickinson
7.6.1 Company profile
7.6.2 Representative Point-of-Care Diagnostics Product
7.6.3 Point-of-Care Diagnostics Sales, Revenue, Price and Gross Margin of Becton Dickinson
7.7 Johnson & Johnson
7.7.1 Company profile
7.7.2 Representative Point-of-Care Diagnostics Product
7.7.3 Point-of-Care Diagnostics Sales, Revenue, Price and Gross Margin of Johnson & Johnson
7.8 Nipro
7.8.1 Company profile
7.8.2 Representative Point-of-Care Diagnostics Product
7.8.3 Point-of-Care Diagnostics Sales, Revenue, Price and Gross Margin of Nipro
7.9 Roche Diagnostics
7.9.1 Company profile
7.9.2 Representative Point-of-Care Diagnostics Product
7.9.3 Point-of-Care Diagnostics Sales, Revenue, Price and Gross Margin of Roche Diagnostics
7.10 Siemens Healthcare
7.10.1 Company profile
7.10.2 Representative Point-of-Care Diagnostics Product
7.10.3 Point-of-Care Diagnostics Sales, Revenue, Price and Gross Margin of Siemens Healthcare
7.11 Samsung Medison
7.11.1 Company profile
7.11.2 Representative Point-of-Care Diagnostics Product
7.11.3 Point-of-Care Diagnostics Sales, Revenue, Price and Gross Margin of Samsung Medison
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF POINT-OF-CARE DIAGNOSTICS
8.1 Industry Chain of Point-of-Care Diagnostics
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF POINT-OF-CARE DIAGNOSTICS
9.1 Cost Structure Analysis of Point-of-Care Diagnostics
9.2 Raw Materials Cost Analysis of Point-of-Care Diagnostics
9.3 Labor Cost Analysis of Point-of-Care Diagnostics
9.4 Manufacturing Expenses Analysis of Point-of-Care Diagnostics
CHAPTER 10 MARKETING STATUS ANALYSIS OF POINT-OF-CARE DIAGNOSTICS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Point-of-Care Diagnostics in This Report
1.2 Commercial Types of Point-of-Care Diagnostics
1.2.1 Glucose Monitoring Kits
1.2.2 Infectious Diseases Testing Kits
1.2.3 Cardiometabolic Monitoring Kits
1.2.4 Coagulation Monitoring Kits
1.2.5 Hematology Testing Kits
1.2.6 Urinalysis Testing Kits
1.2.7 Cholesterol Test Strips
1.2.8 Drugs-Of-Abuse Testing Kits
1.2.9 Tumor/Cancer Markers
1.2.10 Other
1.3 Downstream Application of Point-of-Care Diagnostics
1.3.1 Home
1.3.2 Hospitals
1.3.3 Ambulatory Care
1.4 Development History of Point-of-Care Diagnostics
1.5 Market Status and Trend of Point-of-Care Diagnostics 2013-2023
1.5.1 EMEA Point-of-Care Diagnostics Market Status and Trend 2013-2023
1.5.2 Regional Point-of-Care Diagnostics Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Point-of-Care Diagnostics in EMEA 2013-2017
2.2 Consumption Market of Point-of-Care Diagnostics in EMEA by Regions
2.2.1 Consumption Volume of Point-of-Care Diagnostics in EMEA by Regions
2.2.2 Revenue of Point-of-Care Diagnostics in EMEA by Regions
2.3 Market Analysis of Point-of-Care Diagnostics in EMEA by Regions
2.3.1 Market Analysis of Point-of-Care Diagnostics in Europe 2013-2017
2.3.2 Market Analysis of Point-of-Care Diagnostics in Middle East 2013-2017
2.3.3 Market Analysis of Point-of-Care Diagnostics in Africa 2013-2017
2.4 Market Development Forecast of Point-of-Care Diagnostics in EMEA 2018-2023
2.4.1 Market Development Forecast of Point-of-Care Diagnostics in EMEA 2018-2023
2.4.2 Market Development Forecast of Point-of-Care Diagnostics by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Point-of-Care Diagnostics in EMEA by Types
3.1.2 Revenue of Point-of-Care Diagnostics in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Point-of-Care Diagnostics in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Point-of-Care Diagnostics in EMEA by Downstream Industry
4.2 Demand Volume of Point-of-Care Diagnostics by Downstream Industry in Major Countries
4.2.1 Demand Volume of Point-of-Care Diagnostics by Downstream Industry in Europe
4.2.2 Demand Volume of Point-of-Care Diagnostics by Downstream Industry in Middle East
4.2.3 Demand Volume of Point-of-Care Diagnostics by Downstream Industry in Africa
4.3 Market Forecast of Point-of-Care Diagnostics in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF POINT-OF-CARE DIAGNOSTICS
5.1 EMEA Economy Situation and Trend Overview
5.2 Point-of-Care Diagnostics Downstream Industry Situation and Trend Overview
CHAPTER 6 POINT-OF-CARE DIAGNOSTICS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Point-of-Care Diagnostics in EMEA by Major Players
6.2 Revenue of Point-of-Care Diagnostics in EMEA by Major Players
6.3 Basic Information of Point-of-Care Diagnostics by Major Players
6.3.1 Headquarters Location and Established Time of Point-of-Care Diagnostics Major Players
6.3.2 Employees and Revenue Level of Point-of-Care Diagnostics Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 POINT-OF-CARE DIAGNOSTICS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Abbott Laboratories
7.1.1 Company profile
7.1.2 Representative Point-of-Care Diagnostics Product
7.1.3 Point-of-Care Diagnostics Sales, Revenue, Price and Gross Margin of Abbott Laboratories
7.2 Abaxis
7.2.1 Company profile
7.2.2 Representative Point-of-Care Diagnostics Product
7.2.3 Point-of-Care Diagnostics Sales, Revenue, Price and Gross Margin of Abaxis
7.3 Alere
7.3.1 Company profile
7.3.2 Representative Point-of-Care Diagnostics Product
7.3.3 Point-of-Care Diagnostics Sales, Revenue, Price and Gross Margin of Alere
7.4 Bayer
7.4.1 Company profile
7.4.2 Representative Point-of-Care Diagnostics Product
7.4.3 Point-of-Care Diagnostics Sales, Revenue, Price and Gross Margin of Bayer
7.5 Danaher Corporation
7.5.1 Company profile
7.5.2 Representative Point-of-Care Diagnostics Product
7.5.3 Point-of-Care Diagnostics Sales, Revenue, Price and Gross Margin of Danaher Corporation
7.6 Becton Dickinson
7.6.1 Company profile
7.6.2 Representative Point-of-Care Diagnostics Product
7.6.3 Point-of-Care Diagnostics Sales, Revenue, Price and Gross Margin of Becton Dickinson
7.7 Johnson & Johnson
7.7.1 Company profile
7.7.2 Representative Point-of-Care Diagnostics Product
7.7.3 Point-of-Care Diagnostics Sales, Revenue, Price and Gross Margin of Johnson & Johnson
7.8 Nipro
7.8.1 Company profile
7.8.2 Representative Point-of-Care Diagnostics Product
7.8.3 Point-of-Care Diagnostics Sales, Revenue, Price and Gross Margin of Nipro
7.9 Roche Diagnostics
7.9.1 Company profile
7.9.2 Representative Point-of-Care Diagnostics Product
7.9.3 Point-of-Care Diagnostics Sales, Revenue, Price and Gross Margin of Roche Diagnostics
7.10 Siemens Healthcare
7.10.1 Company profile
7.10.2 Representative Point-of-Care Diagnostics Product
7.10.3 Point-of-Care Diagnostics Sales, Revenue, Price and Gross Margin of Siemens Healthcare
7.11 Samsung Medison
7.11.1 Company profile
7.11.2 Representative Point-of-Care Diagnostics Product
7.11.3 Point-of-Care Diagnostics Sales, Revenue, Price and Gross Margin of Samsung Medison
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF POINT-OF-CARE DIAGNOSTICS
8.1 Industry Chain of Point-of-Care Diagnostics
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF POINT-OF-CARE DIAGNOSTICS
9.1 Cost Structure Analysis of Point-of-Care Diagnostics
9.2 Raw Materials Cost Analysis of Point-of-Care Diagnostics
9.3 Labor Cost Analysis of Point-of-Care Diagnostics
9.4 Manufacturing Expenses Analysis of Point-of-Care Diagnostics
CHAPTER 10 MARKETING STATUS ANALYSIS OF POINT-OF-CARE DIAGNOSTICS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
